- Conditions
- Migraine
- Interventions
- metoclopramide, Diphenhydramine 25mg
- Drug
- Lead sponsor
- Montefiore Medical Center
- Other
- Eligibility
- 18 Years to 69 Years
- Enrollment
- 349 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- The Bronx, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 73–96
of 742
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Pain From onabotulinumtoxinA Injections
- Interventions
- onabotulinumtoxinA prophylaxis with Lidocaine, OnabotulinumtoxinA prophylaxis with Saline
- Procedure
- Lead sponsor
- Association of Migraine Disorders
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- East Providence, Rhode Island
- Conditions
- Migraine Disorders
- Interventions
- Prochlorperazine
- Drug
- Lead sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 1
- States / cities
- Torrance, California
- Conditions
- Migraine
- Interventions
- lasmiditan 200 mg
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017
- U.S. locations
- 2
- States / cities
- Orlando, Florida • Knoxville, Kentucky
- Conditions
- Ménière
- Interventions
- nortriptyline + topiramate
- Drug
- Lead sponsor
- University of California, Irvine
- Other
- Eligibility
- 25 Years to 85 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Orange, California
- Conditions
- Episodic Migraine, Chronic Daily Migraine
- Interventions
- Not listed
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 33 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Migraine
- Interventions
- PF-05180999, Placebo, 120 mg MR PF-05180999, 360 mg MR PF-05180999, 10 mg cetirizine
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 55 Years · Male only
- Enrollment
- 31 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014
- U.S. locations
- 1
- States / cities
- Saint Paul, Minnesota
- Conditions
- Migraine Headache
- Interventions
- Deep Brain Stimulation of SPG for Migraine
- Device
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Migraine Without Aura
- Interventions
- NXN-188, Placebo
- Drug
- Lead sponsor
- NeurAxon Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 195 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 4
- States / cities
- St. Petersburg, Florida • Atlanta, Georgia • Mount Vernon, New York + 1 more
- Conditions
- Vestibular Migraine
- Interventions
- Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI)
- Other
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 10 Years to 20 Years
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 3
- States / cities
- Needham, Massachusetts • Waltham, Massachusetts • Weymouth, Massachusetts
- Conditions
- Migraine
- Interventions
- Not listed
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 1,884 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2036
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Migraine, Pregnancy Related
- Interventions
- Nerivio, Migraine Relief
- Device · Drug
- Lead sponsor
- Theranica
- Industry
- Eligibility
- 18 Years to 42 Years · Female only
- Enrollment
- 145 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 2
- States / cities
- San Diego, California • Montclair, New Jersey
- Conditions
- Headache (Migraine)
- Interventions
- Lornoxicam 8 mg, Lornoxicam 16 mg, Placebo
- Drug
- Lead sponsor
- POZEN
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 150 participants
- Timeline
- 2005 – 2006
- U.S. locations
- 23
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Little Rock, Arkansas + 20 more
- Conditions
- Migraine
- Interventions
- Oxygen, Room air
- Biological
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Chronic Migraine
- Interventions
- Botulinum toxin type A, Placebo
- Biological · Other
- Lead sponsor
- Ipsen
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 759 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 72
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 61 more
- Conditions
- Vestibulodynia, Temporomandibular Disorder, Fibromyalgia Syndrome, Irritable Bowel Syndrome, Migraines, Tension Headache, Endometriosis, Interstitial Cystitis, Back Pain, Chronic Fatigue Syndrome
- Interventions
- 5% lidocaine/5 mg/ml 0.02% estradiol compound cream, Nortriptyline, Placebo cream, Placebo pill
- Drug
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 209 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 2
- States / cities
- Los Angeles, California • Chapel Hill, North Carolina
- Conditions
- Vestibular Function Tests
- Interventions
- Computerized Rotational Head Impulse Test ( crHIT)-Vertical
- Device
- Lead sponsor
- Neurolign
- Industry
- Eligibility
- 22 Years to 69 Years
- Enrollment
- 186 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2022
- U.S. locations
- 3
- States / cities
- Miami, Florida • Rochester, Minnesota • Pittsburgh, Pennsylvania
- Conditions
- Migraine Disorders, Aphasia
- Interventions
- Language treatment
- Behavioral
- Lead sponsor
- Quality Living, Inc.
- Other
- Eligibility
- 19 Years to 65 Years
- Enrollment
- 1 participant
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Omaha, Nebraska
- Conditions
- Migraine, Migraine Disorders, Headache
- Interventions
- Amitriptyline, Topiramate, Placebo
- Drug
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Other
- Eligibility
- 8 Years to 17 Years
- Enrollment
- 488 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 35
- States / cities
- Phoenix, Arizona • San Francisco, California • Stanford, California + 32 more
- Conditions
- Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Migraine, Classic
- Interventions
- Chiropractic Treatment
- Other
- Lead sponsor
- Harvard University Faculty of Medicine
- Other
- Eligibility
- 20 Years to 55 Years · Female only
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Migraine Disorders
- Interventions
- ALD403, Placebo
- Drug
- Lead sponsor
- Alder Biopharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 898 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 83
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 73 more
- Conditions
- Migraine
- Interventions
- MTX101, Placebo
- Drug
- Lead sponsor
- Manistee Therapeutics
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 78 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025
- U.S. locations
- 7
- States / cities
- La Jolla, California • Santa Monica, California • Miami, Florida + 4 more
- Conditions
- Sphenopalatine Ganglion Nerve Block
- Interventions
- Bupivacaine, angiocatheter
- Drug · Device
- Lead sponsor
- Montefiore Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 220 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- The Bronx, New York
- Conditions
- Migraine With Aura, Migraine Without Aura, Allodynia
- Interventions
- DFN-15, Placebo
- Drug · Other
- Lead sponsor
- Hartford Hospital
- Other
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 51 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- West Hartford, Connecticut